This page requires Adobe Flash Player to display correctly.
This ticker requires Adobe Flash Player to display correctly.

2012 Publications

Astanehe A, Finkbeiner M, Krzywinski M, Fotovati A, Dhillon J, Berquin IM, Mills GB, Marra MA, Dunn SE
MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition
Oncogene, January 2012
PMID: 22249268
Chen E, Xu H, Gordonov S, Lim MP, Perkins MH, Ma’ayan A
Expression2kinases: mRNA profiling linked to multiple upstream regulatory layers
Bioinformatics, January 2012, Volume 28, Issue 1, pp. 105-111
PMID: 22080467
Deng X, Eyster T, Elkasabi Y, Lahann J
Bio-orthogonal polymer coatings for co-presentation of biomolecules
Macromolecular Rapid Communications, April 2012, Chapter 33, Issue 8, pp 640-645
PMID: 22351186
Eke I, Deuse Y, Hehlgans S, Gurtner K, Krause M, Baumann M, Shevchenko A, Sandfort V, Cordes, N
β1 Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy
The Journal of Clinical Investigation, March 2012, Volume 122, Issue 4, pp. 1529-1540
PMID: 22378044
Ihara E, Chappellaz M, Turner S, MacDonald JA
The contribution of protein kinase C and CPI-17 signaling pathways to hypercontractility in murine experimental colitis
Neurogastroenterology & Motility, January 2012, Volume 24, No1, pp. 15-26
PMID: 22093175
Johnson JJ, Petiwala SM, Syed DN, Rasmussen JT, Adhami VM, Siddiqui IA, Kohl AM, Mukhtar H
α-Mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth
Carcinogenesis, February 2012, Volume 33, Issue 2, pp 413-419
PMID: 22159229
Kasper S, Breitenbuecher F, Heidel F, Hoffarth S, Markova B, Schuler M, Fischer T
Targeting MCL-1 sensitizes FLT3-ITD-positive leukemias to cytotoxic therapies
Blood Cancer Journal, March 2012, Volume 2, pp. e60
Patel O, Clyde D, Chang M, Nordlund MS, Steel R, Kemp BE, Pritchard DM, Shulkes A, Baldwin GS
Pro-GRP-derived peptides are expressed in colorectal cancer cells and tumors and are biologically active in vivo
Endocrinology, March 2012, Volume 153, Issue 3, pp.1082-1092
PMID: 22202166
Ricciardi MR, Scerpa MC, Bergamo P, Ciuffreda L, Petrucci MT, Chiaretti S, Tavolaro S, Mascolo MG, Abrams SL, Steelman LS
Therapeutic potential of MEK inhibition in acute myelogenous leukemia: rationale for “vertical” and “lateral” combination strategies
Journal of Molecular Medicine, 2012
Shi C, Miller JD
Sta c 3 epitopes and their application as biomarkers to detect specific IgE
Molecular Immunology, April 2012, Vol. 50, Issue 4, pp. 271-277
PMID: 22424314
Zhang H, Pelech S
Protein microarrays and their potential clinical applications in the era of personalized medicine
Microarrays in Diagnostics and Biomarker Development, 2012, Chapter 6, pp. 55-80
Zhang H, Pelech S, Ruijtenbeek R, Felgenhauer T, Bischoff R, Breitling F, Stadler V
Peptide arrays
Microarrays in Diagnostics and Biomarker Development, 2012, Chapter 7, pp. 81-112
Zuo, Y, Wu Y, Chakraborty, C
Cdc42 negatively regulates intrinsic migration of highly aggressive breast cancer cells
Journal of Cellular Physiology, April 2012, Volume 227, Issue 4, pp. 1399-1407
PMID: 21618528